1985
DOI: 10.1016/0306-9877(85)90120-3
|View full text |Cite
|
Sign up to set email alerts
|

Chronic arachidonic acid eicosanoid imbalance: A common feature in coronary artery disease, hypercholesterolemia, cancer and other important diseases. Significance of desaturase enzyme inhibition and of the arachidonic acid desaturase-independent pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
7
0

Year Published

1985
1985
2010
2010

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(7 citation statements)
references
References 22 publications
0
7
0
Order By: Relevance
“…1 Consumption of EPA has been associated with the prevention of atherosclerosis, the successful treatment of coronary artery disease, and amelioration of chronic inflammatory diseases. [2][3][4][5]…”
mentioning
confidence: 99%
“…1 Consumption of EPA has been associated with the prevention of atherosclerosis, the successful treatment of coronary artery disease, and amelioration of chronic inflammatory diseases. [2][3][4][5]…”
mentioning
confidence: 99%
“…These beneficial clinical effects have ranged from reduced risk of acute myocardial death, 1 nutritional repletion in patients with advanced pancreatic malignancy, 2 respiratory disorders such as cystic fibrosis 3 and autoimmune syndromes. 4,5 Dietary -3 fatty acids are most commonly derived from marine fish oil, although several agricultural sources for -3 oils also exist. In fish oil-derived -3 fatty acids, the most active component is eicosapentaenoic acid (EPA) a C20⌬53 fatty acid, and for the purposes of this article, these terms (-3, fish oil, and EPA) will be used interchangeably.…”
mentioning
confidence: 99%
“…Clinically, we recognize that -3 fatty acids are essential for normal growth and development and that they may also be of benefit in a wide range of disease states, including rheumatoid arthritis, atherosclerosis, acute myocardial death, sepsis, and cancer-associated cachexia. [1][2][3][4][5] Interestingly, a common factor between these clinical conditions is endothelial inflammation, underscoring the significance of -3 fatty acids as antiinflammatory agents. A further focus of our investigations was the potential for defining independent "pharmacologic" activity for -3 fatty acids or identifying synergy between -3 fatty acids and the recently available selective cyclooxygenase (COX) -2 inhibitors; recognizing that both compounds have established antiinflammatory activities and likely common mechanisms of action.…”
mentioning
confidence: 99%
“…These beneficial clinical effects have ranged from reduced risk in acute myocardial death, 1 nutritional repletion in patients with advanced pancreatic malignancy, 2 respiratory disorders such as cystic fibrosis, 3 and autoimmune syndromes. 4,5 Underlying many of these conditions in which there may be a role for the inclusion of -3 lipids is the global concept of systemic inflammation. Inflammation with a significant clinical impact is generally accepted to be the result of the prolonged, inappropriate production and release of proinflammatory mediators, specifically cytokines.…”
mentioning
confidence: 99%
“…BABCOCK ET AL Vol. 28,No. 4 Ms undergo LPS stimulation in the presence of a dose equivalent -6 lipid control, no further increase in TNF-␣ production compared with media-only Ms has been observed.…”
mentioning
confidence: 99%